Nov 11, 2008 · As part of this programme Genzyme opened a new Science Center in Framingham, Massachusetts on 22 September 2008. The new research facility will now serve as a centre for early-stage research using new technology in proteins, antibodies, cell therapy and gene therapy to work on diseases such as Parkinson's disease, various …

Oct 15, 2019 · Framingham makes numerous products for Sanofi Genzyme, including Fabry Disease enzyme replacement therapy Fabrazyme (agalsidase beta) – production of which was moved to the site in 2012 after contamination issues at …

Jan 29, 2025 · HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi stating that FDA inspectors found irregularities with the ...

Jan 25, 2018 · The newly-named Sanofi Genzyme, a subsidiary, is building a new $80 million, 72,000-square-foot bio-manufacturing facility in Framingham to expand the company’s production capacity.

Genzyme?s products are focused on rare genetic diseases, multiple sclerosis, cardiovascular disease, and endocrinology. The company?s commitment to innovation continues today with a substantial development program focused on these fields, …

Jan 22, 2025 · Approximately 20% of bioreactor runs over 30 months were rejected due to contamination issues at Sanofi’s Framingham biologics facility, according to the US FDA.

As the centerpiece of Sanofi Genzyme’s Framingham campus, the Science Center creates a dynamic environment for the company’s research scientists, fostering opportunities for interaction and collaboration.

Find company research, competitor information, contact details & financial data for GENZYME CORPORATION of Framingham, MA. Get the latest business insights from Dun & Bradstreet.

Genzyme Corp. has opened its new US$125m (Euro 85m) Science Center in Framingham, Massachusetts. The facility serves as a central site for early stage research into a variety of medical areas including genetic diseases, cancer, immune diseases, kidney disease, cardiovascular disease, endocrinology and neurological disorders.

Jan 24, 2012 · Genzyme Corporation said Tuesday that the FDA has approved its new manufacturing plant in Framingham, Massachusetts, enabling the company to expand its …